In Vitro Study of the Interaction of Doxorubicin, Thiotepa, and Mitomycin-C, Agents Used for Intravesical Chemotherapy of Superficial Bladder Cancer
Author:
Affiliation:
1. From the Department of Urologic Oncology and the Department of Experimental Therapeutics, Roswell Park Cancer Institute, Buffalo, New York
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Urology
Reference19 articles.
1. An overview of intravesical therapy for superficial bladder tumors;Herr;J. Urol.,1987
2. Introduction and overview of intravesical therapy for superficial bladder cancer;Soloway;Urology,1988
3. Intravesical chemotherapy in a controlled trial with thio-tepa versus doxorubicin hydrochloride;Horn;J. Urol.,1981
4. Influence of thiotepa and doxorubicin instillation at time of transurethral surgical treatment of bladder cancer on tumor recurrence: a prospective, randomized, double-blind, controlled trial;Zincke;J. Urol.,1983
5. Intravesicalthiotepa and mitomycin c treatment immediately after transurethral resection and later for superficial (stages Ta and Tis) bladder cancer: a prospective, randomized, stratified study with crossover design;Zincke;J. Urol.,1985
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Injectable Thermosensitive Nanocomposites Based on Poly(N-vinylcaprolactam) and Silica Particles for Localized Release of Hydrophilic and Hydrophobic Drugs;Langmuir;2023-02-06
2. Alternative therapies in patients with non-muscle invasive bladder cancer;Türk Üroloji Dergisi/Turkish Journal of Urology;2017-11-10
3. Tackling non-muscle invasive bladder cancer in the clinic;Expert Review of Anticancer Therapy;2017-04-11
4. Preclinical optimization of a broad-spectrum anti-bladder cancer tri-drug regimen via the Feedback System Control (FSC) platform;Scientific Reports;2015-06-19
5. Emodin modulates epigenetic modifications and suppresses bladder carcinoma cell growth;Molecular Carcinogenesis;2013-09-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3